SAN FRANCISCO--(BUSINESS WIRE)--Viz.ai, the leader in AI-powered disease detection and intelligent care coordination, today announced it has received U.S. Food and Drug Administration (FDA) 510(k) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback